Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers

International Journal of Cancer

Volumn 83, Issue 1, 1999, Pages 45-49

  Jacquemier, Jocelyne ^a   Eisinger, François ^a   Noguès, Catherine ^b   Sun, Zhen Zhu ^a,c   Guinebretière, Jean Marc ^d   Peyrat, Jean Philippe ^a   Geneix, Jeanine ^a,e   Lidereau, Rosette ^b   Birnbaum, Daniel ^e,f   Sobol, Hagay ^a,e  

^a INSTITUT PAOLI CALMETTES   (France)

^b Rene Huguenin Hospital   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d CENTRE OSCAR LAMBRET   (France)

^e INSERM   (France)

^f Jiangxi Provincial People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; STEROID RECEPTOR; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CELL ADHESION; DNA DETERMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BRCA1 PROTEIN; BREAST; BREAST NEOPLASMS; CADHERINS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LINKAGE (GENETICS); MICROSATELLITE REPEATS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS;

EID: 0032859490     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990924)83:1<45::AID-IJC9>3.0.CO;2-G     Document Type: Article

References (29)

1. BECKER, K., ATKINSON, M., REICH, U., BECKER, I., NEKARDA, H., SIEWERT, J. and HOFLER, H., E-cadherin gene mutations provide clues to diffuse type of gastric carcinomas. Cancer Res., 54, 3845-3852 (1994).
2. BERX, G., CLETON-JANSEN, A., STRUMANE, K., DELEEUW, W., NOLLET, F., VAN ROY, F. and CORNELISSE, C., E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene, 181, 1919-1925 (1996).
3. BREAST CANCER LINKAGE CONSORTIUM, Pathology of familial breast cancer: differences between cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet, 349, 1505-1510 (1997).
4. EISINGER, F., JACQUEMIER, J., CHARPIN, C., STOPPA-LYONNET, D., BRESSAC-DE PAILLERETS, B., PEYRAT, J.-P., LONGY, M., GUINEBRETIÈRE, J.-M., SAUVAN, R., NOGUCHI, T., BIRNBAUM, D. and SOBOL, H., Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res., 58, 1588-1592 (1998).
5. EISINGER, F., JACQUEMIER, J., GUINEBRETIÈRE, J.-M., BIRNBAUM, D. and SOBOL, H., p53 involvement in BRCA1-associated breast cancer. Lancet, 350, 1101 (1997).
6. EISINGER, F., NOGUES, C., GUINEBRETIÈRE, J.-M., PEYRAT, J.-P., BARDOU, V.-J., NOGUCHI, T., VENNIN, P., SAUVAN, R., LIDEREAU, R., BIRNBAUM, D. and SOBOL, H., Novel indications for BRCA1 screening using individual clinical and morphological features. Int. J. Cancer, 84, 263-267 (1999).
7. EISINGER, F., STOPPA-LYONNET, D., LONGY, M., KERANGUEVEN, F., NOGUCHI, T., BAILLY, C., VINCENT-SALOMON, A., JACQUEMIER, J., BIRNBAUM, D. and SOBOL, H., Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res., 56, 471-474 (1996).
8. FORD, D. AND 38 OTHERS, Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Amer. J. hum. Genet., 62, 679-689 (1998).
9. GREENLAND, S., Modeling and variable selection in epidemiologic analysis. Amer. J. publ. Health, 79, 340-349 (1989).
10. GRUNWALD, G.B., The structural and functional analysis of cadherin calcium dependent cell adhesion molecules. Curr. Opin. Cell. Biol., 5, 797-805 (1993).
11. GUILFORD, P., HOPKINS, J., HARRAWAY, J., MCLEOD, M., MCLEOD, N., HARAWIRA, P., TAITE, H., SCOULAR, R., MILLER, A. and REEVE, A., E-cadherin germ-line mutations in familial gastric cancer. Nature, 392, 402-405 (1998).
12. GUMBINER, B.M., Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell, 84, 345-357 (1996).
13. HAKEM, R. AND 15 OTHERS, The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell, 85, 1009-1023 (1996).
14. JACQUEMIER, J., PENAULT-LLORCA, F., BERTUCCI, F., SUN, Z., HOUVENAEGHEL, G., GENEIX, J., PUIG, B., BARDOU, V.-J., HASSOUN, J., BIRNBAUM, D. and VIENS, P., Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy. J. Pathol., 184, 130-135 (1998).
15. JONES, J., ROYAL, J. and WALKER, R., E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Brit. J. Cancer, 74, 1237-1241 (1996).
16. LAKHANI, S. AND 40 OTHERS, Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. nat. Cancer Inst., 90, 1138-1145 (1998).
17. MARCUS, J., WATSON, P., PAGE, D., NAROD, S., LENOIR, S., TONIN, P., LINDER-STEPHENSON, L., CONWAY, T. and LYNCH, H., Hereditary breast cancer : pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer, 77, 697-709 (1996).
18. MAZOYER, S., LALLE, P., NAROD, S.A., BIGNON, Y.-J., COURJAL, F., JAMOT, B., DUTRILLAUX, B., STOPPA-LYONNET, D. and SOBOL, H., Linkage analysis of 19 French breast cancer families, with five chromosome 17q markers. Amer J. hum. Genet., 52, 754-760 (1993).
19. MCCUTCHEON, M., COMAN, D. and MOORE, F., Adhesivness of malignant cells in various human adenocarcinomas. Cancer, 1, 460-467 (1948).
20. MOLL, R., MITZE, M., FRIXEN, U. and BIRCHMEIER, W., Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Amer. J. Pathol., 143, 1731-1742 (1993).
21. OKA, H., SHIZAKI, H., KOBAYASHI, K., INOUE, M., TAHARA, H., KOBAYASHI, T., TAKATSUKA, Y., MATSUYOSHI, N., HIRANO, S., TAKEICHI, M. and MORI, T., Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res., 53, 1696-1701 (1993).
22. PEDERSEN, L., Medullary carcinoma of the breast. Acta pathol. microbiol. immunol. Scand. (Suppl.), 105, 5-31 (1997).
23. RAPIN, V., CONTESSO, G., MOURIESSE, H., BERTIN, F., LACOMBE, M., PIEKARSKI, J., TRAVAGLI, J., GADENNE, C. and FRIEDMAN, S., Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer, 61, 2503-2510 (1988).
24. RIDOLFI, R., OSEN, P., PORT, A., KINNE, D. and MIKE, V., Medullary carcinoma of the breast: a clinicopathologic study with 10 years follow-up. Cancer, 40, 1365-1385 (1977).
25. SIITONEN, S., KONONEN, J., HELIN, H., RANTALA, I., HOLLI, K. and ISOLA, J., Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Amer. J. clin. Pathol., 105, 394-402 (1996).
26. SOBOL, H., MAZOYER, S., NAROD, S., SMITH, S., BLACK, D., KERBRAT, P., JAMOT, B., SOLOMON, E., PONDER, B. and GURIN, D., Genetic heterogeneity of early onset familial breast cancer. Hum. Genet., 89, 381-383 (1992).
27. SOBOL, H., STOPPA-LYONNET, D., BRESSAC-DE-PAILLERETS, B., PEYRAT, J.P., KERANGUEVEN, F., JANIN, N., NOGUCHI, T., EISINGER, F., GUINEBRETIÈRE, J.M., JACQUEMIER, J. and BIRNBAUM, D., Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res., 56, 3216-3219 (1996).
28. TAKEICHI, M., Cadherin cell adhesion receptors as morphogenetic regulator. Science, 251, 1451-1455 (1991).
29. UMBAS, R., SCHALKEN, J., AALDERS, T., CARTER, B., KARTHAUS, H., EWOUT SCHAAFSMA, H., DEBRUYNE, F. and ISAACS, W., Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res., 52, 5104-5109 (1992).